All posts by imreal

Navigating the Small Molecule CMC Pathway: Strategies for Avoiding…


In this free webinar, learn about drug substance, formulation development, and regulatory considerations for improving downstream clinical outcomes. Attendees will gain insights into the benefits on…

(PRWeb January 05, 2023)

Read the full story at https://www.prweb.com/releases/navigating_the_small_molecule_cmc_pathway_strategies_for_avoiding_regulatory_hurdles_and_early_drug_development_pitfalls_upcoming_webinar_hosted_by_xtalks/prweb19098076.htm

Elena Fedorov’s newly released “Creation Praising God” is a charming children’s work that celebrates the joy in praising God


News Image

“Creation Praising God”: a delightful celebration of both creation and the Creator. “Creation Praising God” is the creation of published author Elena Fedorov, a dedicated wife and mother of four who was born and raised in Russia until her family immigrated to the United States in the mid-1980s.

Fedorov shares, “The beautiful world around us is crying out glory and honor and praise to our Creator. The birds, the stars, the trees—they all worship Him by doing what they were created to do. Introduce your children to biblical language, encourage them to notice the beautiful world around us, and train them that they, too, can worship God because He is worthy of all praise.”

Published by Christian Faith Publishing, Elena Fedorov’s new book features eye-catching illustrations crafted by Margarita Seroshtan.

Fedorov shares an empowering message of connection with God found in all things both great and small within the pages of her thoughtful children’s work.

Consumers can purchase “Creation Praising God” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Creation Praising God,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Using Artificial Intelligence (AI) to Identify Clonally Derived Cell…


In this free webinar, learn how new artificial intelligence-driven imaging technology is being used to identify single cells automatically on day 0, saving days to weeks of labor and time and…

(PRWeb January 05, 2023)

Read the full story at https://www.prweb.com/releases/using_artificial_intelligence_ai_to_identify_clonally_derived_cell_lines_see_the_future_today_upcoming_webinar_hosted_by_xtalks/prweb19098010.htm

Vet Set Go and VCA Animal Hospitals Team Up to Launch “Become a Veterinarian Camp Contest 2023”


Chris Carpenter, DVM, founder & president of Vet Set Go, with past “Become a Veterinarian Camp Contest” winners. The 2023 online essay contest opens Tues, Feb 1, with entries due by Thurs, March 31.

Vet Set Go and VCA are expanding the 2023 essay contest to be the biggest yet: The contest will award 45 students from across the U.S. – an entire class – a scholarship prize package to attend Vet Camp.

To help aspiring young veterinarians start now to pursue their dream, Vet Set Go and VCA Animal Hospitals are inviting rising sixth-, seventh- and eighth-grade students to enter the seventh annual Vet Set Go “Become a Veterinarian Camp Contest 2023.” Winners of the online essay contest will receive a scholarship to attend the Auburn University Junior Vet Camp from June 18 – 23, 2023, at Auburn University College of Veterinary Medicine, one of the nation’s premier veterinarian schools.

Vet Set Go and VCA are expanding the 2023 essay contest to be the biggest yet: The contest will award 45 students from across the U.S. – an entire class – a scholarship prize package to attend Vet Camp.

“Vet Set Go is proud to offer young aspiring veterinarians an even greater opportunity this year to access the in-person, hands-on veterinary experience they are craving,” said Chris Carpenter, DVM, founder and president of Vet Set Go. “We know what it’s like to have a future veterinarian in your home and are honored to provide this once-in-a-lifetime scholarship opportunity for 45 teens and tweens to explore their dream.”

The prize package is valued at $1,200 and includes tuition, materials, and room and board at the world-renowned Auburn Junior Veterinary Camp in Auburn, Alabama. Transportation to the camp is the responsibility of the winners. The contest opens on Wednesday, February 1, 2023, at 8 a.m. EST, and runs for two months, with online essay submission available at Vet Set Go. The contest ends on Friday, March 31, 2023, with all essays due by 11:59 p.m. EST. Winners will be notified of their free Junior Vet Camp experience by May 15, 2023.

“Those of us in veterinary medicine experience the joy that comes with getting to know pet owners and pets over a lifetime. Vet Set Go plays a critical role in connecting young people to these fulfilling careers,” said Todd Lavender, DVM, president of VCA Animal Hospitals. “I’m proud of our growing partnership with Vet Set Go and excited that we’re able to send a whole class of students to Junior Vet Camp in 2023. This work is one way we’re helping the next generation of professionals grab hold of their dreams and supporting our commitment to taking care of the future of veterinary medicine.”

Vet Set Go has been connecting and mentoring aspiring veterinarians since 2006 and launched the camp scholarship contest in 2017. Since then, Vet Set Go has given away more than 25,000 copies of its award-winning, roadmap-to-becoming-a-veterinarian book to students, and connected hundreds of thousands of teens and tweens to vet-related resources, activities and volunteer opportunities.

The Vet Set Go “Become a Veterinarian Camp Contest” is open to students entering sixth through eighth grade in fall 2023. With the help of a parent or guardian, students enter the contest using the official entry form available Wednesday, February 1, at Vet Set Go. Student entrants are asked to complete a short online essay (300 words or less) that addresses at least one of these topics:


  • Why they want to be a veterinarian
  • Why they love animals
  • What they have done to get animal experience or learn more about science

“I was 11 years old when I decided to become a veterinarian. I still remember how badly I wanted to get out and work with animals and veterinarians, but that experience was so hard to find at that age,” adds Dr. Carpenter. “That’s why I started Vet Set Go 16 years ago. We understand future veterinarians like no other organization and are committed to helping them find opportunities to explore their dream. The ‘Become a Veterinarian Camp Contest’ is a great example of the many ways we help future veterinarians. We understand them like no one else.”

During the camp, contest winners will learn about veterinary medicine first-hand in Auburn University classrooms, laboratories, and outdoor facilities. Curriculum includes learning about surgery, food animals, wildlife, anatomy, parasitology, and first aid, as well as gaining valuable mentoring about veterinary science careers.

To learn more about the “Become a Veterinarian Camp Contest 2023” or to enter between February 1 and March 31, 2023, visit http://www.vetsetgo.com.

ABOUT Vet Set Go

Vet Set Go is the first and only web community dedicated to helping teen and tween aspiring veterinarians explore their passion. Founded by Dr. Christopher Carpenter in 2006, Vet Set Go encourages future veterinarians to pursue their dream and shows them how they can start today through such resources as its award-winning Vet Set Go book and the online Vet Academy shadowing courses. Vet Set Go’s Vet Volunteer app is the best way for students to find local volunteer opportunities while tracking their volunteer hours for veterinary college applications. Vet Set Go also introduces STEM subjects to aspiring veterinarians through online courses like “Introduction to Animal Anatomy” and free case study articles on the website. Proceeds from Vet Set Go sales help aspiring veterinarians through events like the “Become a Vet Camp Contest” and Vet Set Go book giveaways to students in need. For more information, visit http://www.vetsetgo.com

ABOUT VCA ANIMAL HOSPITALS

A leader in veterinary care, VCA Animal Hospitals is committed to taking care of the future of veterinary medicine. We are a family of hometown animal hospitals determined to positively impact pets, people and our communities. From general practice to emergency and specialty care, VCA delivers world-class medicine and hometown care to more than four million pets each year. We invest in cutting-edge tools, training and technology that enable Associates across our national network of hospitals to lead the industry today and into tomorrow. Among our talented 35,000 Associates are nearly 7,000 veterinarians – including 430 who are board-certified specialists – nearly 4,000 credentialed technicians and over 10,000 veterinary assistants – all dedicated to giving pets the very best in medical care.

As part of the Mars Veterinary Health family of brands, VCA is taking care of the future of veterinary medicine to help achieve the Mars Petcare Purpose—A Better World for Pets™. To learn more about VCA, visit: http://www.vca.com or find us on Facebook, Instagram, Twitter and LinkedIn.

ABOUT Auburn Junior Veterinary Camp

The Auburn University College of Veterinary Medicine offers the Auburn Junior Veterinary Camp on its campus in Auburn, Alabama each summer for youth entering the sixth- through eighth-grade who are interested in the veterinary medicine profession. Faculty, technicians and second-year veterinary students provide unique veterinary coursework and experiences for campers in laboratories, classrooms and outdoor facilities in one of the nation’s premiere veterinary schools. Over the course of its 125-year plus history, the Auburn University has produced more than 6,400 veterinarians and more than 500 specialists and researchers.

Share article on social media or email:



Potential New Targets Identified in Advanced Non-Alcoholic Fatty Liver Disease


Hepatic stellate cells along with their intricate cellular projections (green) are shown wrapped around blood vessels (gray) in the healthy liver.

Using the latest technologies—including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD). The research was led by investigators at the Icahn School of Medicine at Mount Sinai.

Utilizing these innovative methods, the investigators discovered a network of cell-to-cell communication driving scarring as liver disease advances. The findings, published online on January 4 in Science Translational Medicine, could lead to new treatments.

Characterized by fat in the liver and often associated with type 2 diabetes, hypertension, and elevated blood lipids, NAFLD is a worldwide threat. In the United States, 30 to 40 percent of adults are estimated to be affected, with about 20 percent of these patients having a more advanced stage called non-alcoholic steatohepatitis, or NASH, which is marked by liver inflammation and may progress to advanced scarring (cirrhosis) and liver failure.

NASH is also the fastest-rising cause of liver cancer worldwide. Since advanced stages of NASH are caused by the accumulation of fibrosis or scarring, attempts to block fibrosis are at the center of efforts to treat NASH, yet no drugs are currently approved for this purpose, say the investigators.

As part of the experiments, the researchers performed single-nuclear sequencing in parallel studies of both mouse models of NASH and human liver tissue from nine subjects with NASH and two controls. They identified a shared number of 68 pairs of potential drug targets across the two species. Furthermore, the investigators pursued one of these pairs by testing an existing cancer drug in mice as a proof of concept.

“We aimed to understand the basis of this fibrotic scarring and identify drug targets that could lead to new treatments for advanced NASH by studying hepatic stellate cells, which are the key scar-producing cells in the liver,” said senior study author Scott L. Friedman, MD, Irene and Dr. Arthur M. Fishberg Professor of Medicine, Dean for Therapeutic Discovery, and Chief of Liver Diseases at Icahn Mount Sinai. “In combining this new glass liver imaging approach—an advanced tissue clearing method that enables deep insight—along with gene expression analysis in individual stellate cells, we have unveiled an entirely new understanding of how these cells generate scarring as NASH advances to late stages.”

The researchers discovered that in advanced disease, stellate cells develop a dense network, or meshwork, of interactions among themselves that facilitate these 68 unique interaction pairs not previously identified in this disease.

“We confirmed the importance of one such pair of proteins, NTF3-NTRK3, using a molecule already developed to block NTRK3 in human cancers and repurposed it to establish its potential as a new drug to fight NASH fibrosis,” said first author Shuang (Sammi) Wang, PhD, an instructor in the Division of Liver Diseases. “This new understanding of fibrosis development suggests that advanced fibrosis may have a unique repertoire of signals that accelerate scarring, which represent a previously unrecognized set of drug targets.”

The researchers hypothesize that the circuitry of how cells communicate with each other evolves as the disease progresses, so some drugs may be more effective earlier and others at more advanced stages. And the same drug may not work for all stages of disease.

The investigators are currently working with Icahn Mount Sinai chemists to further optimize NTRK3 inhibitors for the treatment of liver fibrosis. Next, the investigators plan to functionally screen all candidate interactors in a cell-culture system, followed by testing in preclinical models of liver disease, as they have done for NTRK3. In addition, they hope to extend their efforts to determine if similar interactions among fibrogenic cells underlie fibrosis of other tissues including heart, lung, and kidneys.

The paper is titled “An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in non-alcoholic steatohepatitis.”

Additional co-authors are: Kenneth Li (Icahn Mount Sinai); Eliana Pickholz Li (Icahn Mount Sinai); Ross Dobie (University of Edinburgh, UK); Kylie P. Matchett (University of Edinburgh, UK); Neil C. Henderson (University of Edinburgh, UK); Chris Carrico (Gordian Biotechnology, CA); Ian Driver (Gordian Biotechnology, CA); Martin Borch Jensen (Gordian Biotechnology, CA); Li Chen PharmaNest, Inc., NJ); Mathieu Petitjean (PharmaNest, Inc.,NJ); Dipankar Bhattacharya (Icahn Mount Sinai); Maria I. Fiel (Icahn Mount Sinai); Xiao Liu (University of California); Tatiana Kisseleva (University of California); Uri Alon (Weizmann Institute of Science, Israel); Miri Adler (Yale University School of Medicine, CT); Ruslan Medzhitov (Yale University School of Medicine, CT).

The work was supported, in part, by funds from the National Institutes of Health grant numbers R01DK56621, R01DK128289, TR004419, P30CA196521, R01DK101737, R01DK099205, R01DK111866, R01AA028550, P50AA011999, P30 DK120515, and U01AA029019.

-####-

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight-member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 35 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

  • Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

Nicole Rocke’s newly released “Mya in the Mirror” is a creative teaching tool that encourages young readers to trust in God for guidance


News Image

“Mya in the Mirror”: a delightful juvenile fiction with an important message of faith. “Mya in the Mirror” is the creation of published author Nicole Rocke.

Rocke shares, “Mya thought that she would have a regular Sunday with her family. This meant going to church and Sunday school in the morning, followed by her mom making an amazing meal for them to enjoy at home. However, she would soon learn that this Sunday was anything but regular with the trip to the carnival after church. There will be fun games, rides, prizes to win, and cotton candy. Imagine thinking that you are going to have a wonderful time at the carnival with your family only for you to end up getting lost. How could this be? How will Mya get back to her family? Could Mya be lost forever? What will Mya face while she is lost? Who will she meet? What lessons will she learn? Who will save Mya?”

Published by Christian Faith Publishing, Nicole Rocke’s new book brings an important lesson of faith to life in a new and innovative way.

Rocke shares in hopes of aiding upcoming generations in their understanding of scripture by crafting a fun adventure with important meaning.

Consumers can purchase “Mya in the Mirror” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Mya in the Mirror,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

The Lord Has Spoken” is an enjoyable selection of inspiring poetry


News Image

“Being with the One: The Lord Has Spoken”: an engaging collection of moving verse. “Being with the One: The Lord Has Spoken” is the creation of published author Sir William Ralph Landrum Tolbert.

Tolbert shares, “The Lord planted his love, in my heart

And soul, that I may be able to see His vision, to do his will.”

Published by Christian Faith Publishing, Sir William Ralph Landrum Tolbert’s new book will resonate with the soul as readers reflect on the elegant stanzas within.

Tolbert shares deeply personal works inspired by his personal faith for the enjoyment and encouragement of all.

Consumers can purchase “Being with the One: The Lord Has Spoken” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Being with the One: The Lord Has Spoken,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

New ezAccounting 2023 Software Released To Help Businesses Increase Efficiency This Tax Season


News Image

In House Accounting & Payroll Software for Businesses, Non-profits and Accountants

ezAccounting 2023 software currently being offered to help businesses become more efficient for the upcoming busy tax season,

Latest 2023 ezAccounting payroll and business task software helps businesses be more productive during this economic downturn. Customers can easily receive money from clients, pay employees and pay vendors faster. Halfpricesoft.com has updated and released this new version to accommodate business owners in the upcoming tax season

“ezAccounting 2023 software currently being offered to help businesses become more efficient for the upcoming busy tax season,” said Dr. Ge, Founder of Halfpricesoft.com.

Potential customers can now download and test it for up to 30 days with no obligation to purchase. Test drive at: https://www.halfpricesoft.com/accounting/accounting-software.asp

ezAccounting is the most economical solution for businesses to track income and expenses, process payroll, print checks, generate reports and print tax forms. The main features include, but are not limited to:


  • Generates invoices, receipts, purchase orders
  • Tracks income and expenses
  • Generates estimates, invoices and receipts
  • Prints checks and tracks transactions
  • Manages purchase orders and bill paying
  • Processes payroll checks for employees
  • Prints tax forms 941, 940, W2 and W3 (Preprinted Copy A Forms required for W2 and W3)
  • Generates multiple reports for sales, orders, payroll and other business reports
  • Supports multiple companies with one flat rate on the same machine
  • Network version available
  • Check validation not required

ezAccounting is currently priced at $179 for a single installation version per calendar year, (limited time at $209 single installation for both 2022 and 2023 ezAccounting for payroll and business tasks processing. Regular price: $179 for one year for a single installation). ezAccounting software is affordable for any size business. Customers seeking a way to simplify business operations are welcome to start the no obligation 30-day test drive today at: https://www.halfpricesoft.com/accounting/accounting-software.asp

About halfpricesoft.com

Halfpricesoft.com is a leading provider of small business software, including online and desktop payroll software, online employee attendance tracking software, accounting software, in-house business and personal check printing software, W2, software, 1099 software, accounting software, 1095 form software and ezACH direct deposit software. Software from halfpricesoft.com is trusted by thousands of customers and will help small Business owners simplify payroll processing and streamline business management.

Share article on social media or email:

New Year, New Hope for Family Gifted a Much-Needed Wheelchair Van


A young girl in a wheelchair is secured in a red wheelchair van with a side-entry ramp made by BraunAbility. Her family was granted the vehicle as part of a partnership between Laughing at My Nightmare and BraunAbility.

Six-year-old Fynlee Armstrong gets ready for her first ride in the family’s new wheelchair van, which they were surprised with as part of a program celebrating the 50th anniversary of BraunAbility.

“This van will completely change our entire family’s mindset; it will bring peace of mind,” said Jaysa Armstrong. “Now we can think about what we can do instead of what we can’t, all because we now have an accessible vehicle.”

For the last few years, Jaysa Armstrong and her husband, Justin, have lifted their six-year-old daughter, Fynlee, and her wheelchair in and out of their car each time they make their multiple trips to medical visits and treatment appointments.

As she grew older and bigger, the stress and physical strain of transferring Fynlee, a “sassy and spunky little girl” who has Spinal Muscular Atrophy, and her equipment had become more and more difficult for the family of Clyde, TX.

But the new year brings new hope for the Armstrong family, thanks to the donation of a wheelchair accessible vehicle over the holidays made possible by BraunAbility, the global leader in automotive mobility solutions.

“This van will completely change our entire family’s mindset; it will bring peace of mind,” said Jaysa Armstrong. “Now we can think about what we can do instead of what we can’t, all because we now have an accessible vehicle.”

To recognize its 50th anniversary, BraunAbility partnered with nonprofit Laughing at My Nightmare to award the wheelchair accessible vehicle to an individual or family living with Muscular Dystrophy.

Like Fynlee, the founders of both BraunAbility and LAMN were diagnosed with Spinal Muscular Atrophy at a young age, and both used the diagnosis as a catalyst for inclusion for the disability community.

“When our founder, Ralph Braun, was a young man in the 1940s, he faced significant odds. Only he and his family believed he’d become a contributing member of the community someday,” said BraunAbility Senior Brand Manager Megan Wegner. “Ralph literally engineered his own independence, and in doing so, he gave people with mobility challenges the ability to be seen, to be included in society.”

This donation both celebrates BraunAbility’s 50th anniversary and shines a light on families like the Armstrongs who, day in and day out, do whatever it takes to ensure their child with SMA has the same opportunities as other children.

The Armstrong family was surprised with the news during a video call earlier this fall. LAMN announced the giveaway in September, and the winning family was selected in November.

“Many disabled people do not have access to the equipment they need to thrive,” stated Shane Burcaw, founder of LAMN. “Living with a disability myself, I know how frustrating it can be when needs go unmet. We created this organization to fill those gaps for as many people as possible.”

The BraunAbility® CompanionVan® is built on a Pacifica Voyager chassis and features a manual ramp and a lowered floor in the mid-section of the vehicle for easy maneuverability and securement of a wheelchair passenger. The family received the keys to the vehicle and a full overview of its functions at United Access, a BraunAbility mobility dealership with over 30 nationwide locations.

“We can’t wait to see how this BraunAbility wheelchair van enhances this family’s life, and we hope it allows Fynlee to explore the world and participate fully with her peers,” added Burcaw.

Since its founding nearly 10 years ago, LAMN has provided nearly $1 million in adaptive and medical equipment to qualifying individuals and families. Learn more at https://www.laughingatmynightmare.com/.

ABOUT BRAUNABILITY

BraunAbility is the world’s leading manufacturer of mobility transportation solutions, including wheelchair accessible vehicles, wheelchair lifts and seating, storage and securement products. Founded over 50 years ago by Ralph Braun, an entrepreneur who spent most of his life in a wheelchair, the company has grown into the most well-known and trusted name in the mobility industry, bringing independence to millions of individuals across the world. BraunAbility is a wholly owned subsidiary to Patricia Industries, a division of Investor AB Group. Visit https://www.braunability.com/us/en.html for more information.

Share article on social media or email: